• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Align Technology Statement on European Commission Proceeding

    6/30/26 8:21:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care
    Get the next $ALGN alert in real time by email

    Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today responded to the European Commission’s June 30 press release announcing an investigation involving the Company based on a complaint made by an Align competitor.

    Align Technology is committed to conducting business with integrity and in full compliance with global competition laws. We believe fair, lawful competition drives innovation, expands choice, and delivers better outcomes for doctors and patients. Our success in the teeth-straightening market is built on the strength of our products and services — quality, innovation, and customer experience — not on unfair practices, and we strongly dispute any suggestion to the contrary.

    Align’s iTero intraoral scanning platform is designed to support an open and diverse digital dental ecosystem, and supports a wide range of clinical workflows, including implants, restorative dentistry, digital orthodontics, and clear aligner treatment. iTero generated scans can be freely exported to order aligners other than Invisalign aligners. Align maintains a scan acceptance policy designed to ensure clinical quality, patient safety, and system reliability, including validation requirements for digital file submissions and the operational resources needed to support consistent processing across workflows.

    The iTero intraoral scanning platform is used globally by dental professionals across diverse treatment modalities, with millions of scans performed annually, reflecting its role in enabling a broad and competitive marketplace for digital dentistry solutions. Since 2018, the iTero scanner has been used by healthcare professionals to perform over 24 million restorative, wellness, and orthodontic scans.

    The Commission’s step is purely procedural and allows it to gather information. It does not reflect a conclusion on the merits of the case, nor does it constitute an accusation or a finding of wrongdoing. The opening of an investigation does not prejudge its outcome.

    Align is confident that any review of Align’s scanner and scan acceptance policies will reflect the robust and dynamic nature of the teeth-straightening market and believes its practices comply with applicable competition laws. We will cooperate fully and engage constructively with the Commission through the appropriate channels.

    For nearly 30 years, Align Technology has helped transform a market long dominated by wires and brackets, offering meaningful choices to customers across Europe and around the world. By introducing innovative digital dentistry solutions that expand treatment possibilities for doctors and their patients, Align has helped doctors transform smiles and change lives for millions of patients, a testament to the value of innovation and better patient experience. What began as an innovation has grown into a widely accepted treatment category, one that now extends beyond Invisalign aligners and iTero scanners across a diverse and competitive ecosystem.

    About Align Technology, Inc.

    Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for approximately 299.5 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 29 years, Align has helped doctors treat approximately 22.8 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

    For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

    Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260630727149/en/

    Align Technology

    Madelyn Valente

    (909) 833-5839

    mvalente@aligntech.com

    Zeno Group

    Sarah Karlson

    (828) 551-4201

    sarah.karlson@zenogroup.com

    Get the next $ALGN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALGN

    DatePrice TargetRatingAnalyst
    7/9/2026$209.00Outperform
    BMO Capital Markets
    4/15/2026$240.00Buy
    Citigroup
    3/17/2026$200.00Equal Weight → Overweight
    Barclays
    2/9/2026$200.00Hold → Buy
    HSBC Securities
    12/9/2025$170.00Equal Weight
    Barclays
    10/10/2025$140.00Buy → Hold
    Jefferies
    7/31/2025$154.00Overweight → Equal-Weight
    Morgan Stanley
    4/25/2025$170.00Buy → Hold
    HSBC Securities
    More analyst ratings

    $ALGN
    SEC Filings

    View All

    Align Technology Inc. filed SEC Form 8-K: Leadership Update

    8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    7/8/26 8:29:04 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    6/18/26 9:02:10 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SD filed by Align Technology Inc.

    SD - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    5/29/26 4:13:54 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Vitalone Britt J. converted options into 1,443 shares (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    5/22/26 7:18:21 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Director Siegel Susan E converted options into 1,745 shares, increasing direct ownership by 19% to 10,723 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    5/22/26 7:16:21 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Director Saia Andrea Lynn converted options into 1,745 shares, increasing direct ownership by 11% to 17,318 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    5/22/26 7:15:13 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Operation Smile Announces Align Technology as Title Sponsor of 34th International Student Leadership Conference for Sixth Year

    Over six years, Align has contributed more than $2M to Operation Smile's student programs to send the next generation of global health advocates to the world stageVIRGINIA BEACH, Va., and TEMPE, Ariz., July 14, 2026 /PRNewswire/ -- Operation Smile, a global nonprofit deeply committed to closing the gap in surgical and health care access, today announced Align Technology, Inc. (NASDAQ:ALGN) as the title sponsor of its 2026 International Student Leadership Conference (ISLC), marking the sixth consecutive year of this sponsorship. Through nearly $3.8 million in total contributions benefiting Operation Smile's students and surgical programs, Align Technology is a key global partner, supporting y

    7/14/26 9:00:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology to Announce Second Quarter 2026 Results on July 29, 2026

    Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2026 financial results on Wednesday, July 29, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com.Following the press release, Align will host a conference call to discuss its financial results. The conference call will begin a

    7/1/26 8:30:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Statement on European Commission Proceeding

    Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today responded to the European Commission’s June 30 press release announcing an investigation involving the Company based on a complaint made by an Align competitor. Align Technology is committed to conducting business with integrity and in full compliance with global competition laws. We believe fair, lawful competition drives innovation, expands choice, and delivers better outcomes for doctors and patients. Our suc

    6/30/26 8:21:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Align Tech with a new price target

    BMO Capital Markets initiated coverage of Align Tech with a rating of Outperform and set a new price target of $209.00

    7/9/26 9:26:08 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Citigroup initiated coverage on Align Tech with a new price target

    Citigroup initiated coverage of Align Tech with a rating of Buy and set a new price target of $240.00

    4/15/26 8:07:32 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Tech upgraded by Barclays with a new price target

    Barclays upgraded Align Tech from Equal Weight to Overweight and set a new price target of $200.00

    3/17/26 7:53:01 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann bought $4,606 worth of shares (42 units at $109.66), increasing direct ownership by 0.59% to 7,110 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 5:58:45 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    PRESIDENT AND CEO Hogan Joseph M bought $996,131 worth of shares (7,576 units at $131.49), increasing direct ownership by 4% to 184,945 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 4:05:18 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Director Larkin C Raymond Jr bought $1,529,645 worth of shares (6,500 units at $235.33) and gifted 4,650 shares, increasing direct ownership by 9% to 23,597 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/19/24 6:35:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Financials

    Live finance-specific insights

    View All

    Align Technology to Announce Second Quarter 2026 Results on July 29, 2026

    Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2026 financial results on Wednesday, July 29, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com.Following the press release, Align will host a conference call to discuss its financial results. The conference call will begin a

    7/1/26 8:30:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Announces First Quarter 2026 Financial Results, $200M Stock Repurchase, and Reaffirms Fiscal 2026 Guidance

    Record Q1'26 Invisalign® Clear Aligner shipments of 685.7 thousand increased 6.7% year-over-year reflecting double-digit growth in the EMEA, APAC, and LATAM regions, and stability in North America Q1'26 Clear Aligner shipments to Orthodontists and GP Dentists increased 7.4% and 5.6% year-over-year, respectively Q1'26 Invisalign teen/kid patients increased 4.8% year-over-year and Invisalign adult patients increased 7.8% year-over-year Q1'26 total revenues were $1,040.1 million, down 0.7% sequentially and up 6.2% year-over-year Q1'26 total revenues were favorably impacted by foreign exchange by approximately $8.7 million sequentially, and favorably impacted by approximately $44.9 mi

    4/29/26 4:05:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology to Announce First Quarter 2026 Results on April 29, 2026

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2026 financial results on Wednesday, April 29, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be

    4/1/26 4:23:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/13/24 4:59:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/24 4:31:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/23 11:07:31 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Leadership Updates

    Live Leadership Updates

    View All

    Align Technology Announces Board Leadership Transition. C. Raymond Larkin, Jr. to Retire as Chairman and Kevin Conroy to be Appointed Chairman Effective July 1, 2026

    Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that C. Raymond Larkin, Jr. will retire as Chairman of the Board effective July 1, 2026, following more than 20 years of distinguished service on Align's Board of Directors. Mr. Larkin will continue to serve on the Board and as a member of the Nominating and Governance Committee through December 31, 2026, to support a smooth transition. Kevin Conroy will succeed Mr. Larkin as Chairman of the Board, eff

    6/18/26 9:01:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC

    Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are

    3/25/25 4:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company's Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res

    5/22/24 5:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care